Total Clarity Wealth Management, Inc. Longeveron Inc. Transaction History

Total Clarity Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$2.92 - $42.3 $2,920 - $42,300	-1,000 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$3.4 - $8.3 $3,400 - $8,300	1,000 New	1,000 $4,000
Q2 2021 Jul 26, 2021	SELL	$5.2 - $8.13 $5,200 - $8,130	-1,000 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$5.66 - $8.45 $5,660 - $8,450	1,000 New	1,000 $7,000

581

Ticker LGVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,925,940
Market Cap $12.4M
Description
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult ...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.